Vinorelbine is one of the most active cytotoxic agents in breast cancer, especially metastatic breast cancer and bioinformatics analysis indicated that TGF-β signaling pathway may associate with drug resistance of breast cancer cells to vinorelbine [43]. The gene discussed is TGFB1; the disease is breast carcinoma.